Fetal Diagnosis and Therapy

 

Renal Tubular Dysgenesis: Report of Two Cases in a Non-Consanguineous Couple and Review of the Literature

Ramalho C.a · Matias A.a · Brandão O.b · Montenegro N.a

Author affiliations

aCenter of Prenatal Diagnosis, Department of Gynecology and Obstetrics, and bDepartment of Anatomopathology, Medical Faculty of Porto, Hospital S. João, Porto, Portugal

Related Articles for ""

Fetal Diagn Ther 2007;22:10–13

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Paper

Received: August 09, 2005
Accepted: January 30, 2006
Published online: September 21, 2006
Issue release date: December 2006

Number of Print Pages: 4
Number of Figures: 2
Number of Tables: 0

ISSN: 1015-3837 (Print)
eISSN: 1421-9964 (Online)

For additional information: https://www.karger.com/FDT

Abstract

Renal tubular dysgenesis is a rare congenital abnormality of renal development characterized by short and poorly developed proximal convoluted tubules. It is associated to late-appearing oligohydramnios, Potter’s sequence, pulmonary hypoplasia and calvarial bone hypoplasia with enlarged fontanels. The onset of oligohydramnios is delayed and variable, normally later than 22 weeks of gestation, conditioning variation in the expression of the other deformities. We report 2 cases of renal tubular dysgenesis occurring in a non-consanguineous couple.

© 2007 S. Karger AG, Basel




Related Articles:


References

  1. Allanson JE, Pantzar JT, MacLeod PM: Possible new autosomal recessive syndrome with unusual renal histopathological changes. Am J Med Genet. 1983;16:57–60.
  2. Swinford AAE, Bernstein J, Toriello HV, Higgins JV: Renal tubular dysgenesis: delayed onset of oligohydramnios. Am J Med Genet 1989;32:127–132.
  3. Allanson JE, Hunter AGW, Mettler GS, Jimenez C: Renal tubular dysgenesis: A not uncommon autosomal recessive syndrome: a review. Am J Med Genet 1992;43:811–814.
  4. Scarcella A, Pecoraro C, D’Agnello MR, Sole AN: Renal tubular dysgenesis without pulmonary hypoplasia. Pediatr Nephrol 1994;8:216–217.
  5. Morris S, Akima S, Dahlstrom JE, Ellwood D, Kent A, Falk MC: Renal tubular dysgenesis and neonatal hemochromatosis without pulmonary hypoplasia. Pediatr Nephrol 2004;19:341–344.
  6. MacMahon P, Blackie RA, House MJ, Risdon RA, Crawfurd MD: A further family with congenital renal proximal tubular dysgenesis. Am J Med Genet 1990;27:395–398.
  7. Cunniff C, Jones KL, Phillipson J, Benirschke K, Short S, Wujek J: Oligohydramnios sequence and renal tubular malformation associated with maternal enalapril use. Am J Obstet Gynecol 1990;162:187–189.
  8. Kumar D, Moss G, Primhak R, Coombs R: Congenital renal tubular dysgenesis and skull ossification defects similar to teratogenic effects of angiotensin converting enzyme inhibitors. J Med Genet 1997;34:541–545.
  9. Robin YM, Reynaud P, Orliaguet T, Lemery D, Vanlieferingen P, Dechelotte P: Renal tubular dysgenesis-like lesions and hypocalvaria: report of two cases involving indomethacin. Pathol Res Pract 2000;196:791–794.
  10. Voyer LE, Drut R, Mendez JH: Fetal renal maldevelopment with oligohydramnios following maternal use of piroxicam. Pediatr Nephrol 1994;8:592–594.
  11. Barr M, Sedman AB, Heidelberger KP: Renal tubular dysgenesis in twins. Pediatr Nephrol 1998;12:408–413.
  12. Oberg KC, Pestaner JP, Bielamowicz L, Hawkins EP: Renal tubular dysgenesis in twin-twin transfusion syndrome. Pediatr Dev Pathol 1999;2:25–32.
  13. Yosypiv IV, El-Dahr SS: Role of the renin-angiotensin system in the development of the ureteric bud and renal collecting system. Pediatr Nephrol 2005;20:1219–1229.
  14. Kriegsmann J, Wiltrud C, Kommoss F, Beetz R, Hallermann C, Müntefering H: Renal tubular dysgenesis (RTD): an important cause of the oligohydramnion-sequence. Report of 3 cases and review of the literature. Pathol Res Pract 2000;196:861–865.

Article / Publication Details

First-Page Preview
Abstract of Paper

Received: August 09, 2005
Accepted: January 30, 2006
Published online: September 21, 2006
Issue release date: December 2006

Number of Print Pages: 4
Number of Figures: 2
Number of Tables: 0

ISSN: 1015-3837 (Print)
eISSN: 1421-9964 (Online)

For additional information: https://www.karger.com/FDT


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP